Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 3
1982 2
1983 7
1984 4
1985 5
1986 7
1987 6
1988 3
1989 8
1990 7
1991 8
1992 5
1993 12
1994 16
1995 27
1996 24
1997 29
1998 39
1999 53
2000 72
2001 64
2002 69
2003 96
2004 138
2005 182
2006 195
2007 240
2008 289
2009 325
2010 401
2011 480
2012 555
2013 644
2014 783
2015 846
2016 962
2017 1035
2018 1305
2019 1600
2020 1845
2021 2117
2022 916
Text availability
Article attribute
Article type
Publication date

Search Results

13,711 results
Results by year
Filters applied: . Clear all
Page 1
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Huang C, et al. Among authors: xiao y. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Lancet. 2020. PMID: 31986264 Free PMC article.
Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.
Tang J, Tu S, Lin G, Guo H, Yan C, Liu Q, Huang L, Tang N, Xiao Y, Pope RM, Rajaram MVS, Amer AO, Ahmer BM, Gunn JS, Wozniak DJ, Tao L, Coppola V, Zhang L, Langdon WY, Torrelles JB, Lipkowitz S, Zhang J. Tang J, et al. Among authors: xiao y. J Exp Med. 2020 Apr 6;217(4):e20182091. doi: 10.1084/jem.20182091. J Exp Med. 2020. PMID: 31999304 Free PMC article.
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer.
Ye L, Lin C, Wang X, Li Q, Li Y, Wang M, Zhao Z, Wu X, Shi D, Xiao Y, Ren L, Jian Y, Yang M, Ou R, Deng G, Ouyang Y, Chen X, Li J, Song L. Ye L, et al. Among authors: xiao y. EMBO Mol Med. 2019 Dec;11(12):e10638. doi: 10.15252/emmm.201910638. Epub 2019 Oct 28. EMBO Mol Med. 2019. PMID: 31657150 Free PMC article.
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: xiao y. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.
13,711 results
You have reached the last available page of results. Please see the User Guide for more information.